QuiVad

Home / Sweden / Oncopeptides AB

Oncopeptides AB

Short position disclosed on August 11, 2026.

Follow

Evolution of the disclosed total

0%1%2%3%
Oct 2025Jan 2026Apr 2026Jul 2026
Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.
The whole history, peaking at 8.43% on August 19, 2021. The shaded band is the year shown above.

July 23, 2018 today

Open positions

The funds disclosing a short position that is still open.
FundTwelve months% of capitalOver the yearSince
GSA Capital Partners LLP1.30%newAugust 11, 2026
Two Sigma Investments, LP0.57%newJuly 3, 2026

On the other side: the funds that hold Oncopeptides AB Titelia

History of disclosures

437 disclosures on record for this share.
DateFund% of capitalEnd of publication
August 11, 2026GSA Capital Partners LLP1.30%still open
July 28, 2026GSA Capital Partners LLP1.21%still open
July 22, 2026GSA Capital Partners LLP1.11%still open
July 16, 2026GSA Capital Partners LLP1.03%still open
July 10, 2026GSA Capital Partners LLP0.92%still open
July 3, 2026GSA Capital Partners LLP0.81%still open
July 3, 2026Two Sigma Investments, LP0.57%still open
June 26, 2026GSA Capital Partners LLP0.70%still open
June 22, 2026GSA Capital Partners LLP0.60%still open
June 12, 2026Two Sigma Investments, LP0.68%still open
June 12, 2026GSA Capital Partners LLP0.50%still open
June 8, 2026Two Sigma Investments, LP0.78%still open
June 5, 2026Two Sigma Investments, LP0.82%still open
May 29, 2026Two Sigma Investments, LP0.98%still open
May 28, 2026Two Sigma Investments, LP0.82%still open
May 27, 2026Two Sigma Investments, LP0.73%still open
May 25, 2026Two Sigma Investments, LP0.62%still open
May 21, 2026Two Sigma Investments, LP0.75%still open
March 24, 2026Guevoura Fund1.37%still open
March 20, 2026Guevoura Fund1.50%still open
March 19, 2026Guevoura Fund1.49%still open
March 18, 2026Guevoura Fund1.87%still open
March 17, 2026Guevoura Fund1.33%still open
March 16, 2026Guevoura Fund0.81%still open
March 12, 2026Guevoura Fund0.54%still open
January 16, 2026Citadel Securities (Europe) Limited0.65%still open
September 22, 2025Brummer Multi-Strategy AB1.02%still open
September 10, 2025Guevoura Fund0.56%still open
August 26, 2025Brummer Multi-Strategy AB1.24%still open
August 22, 2025Brummer Multi-Strategy AB1.02%still open
August 21, 2025Brummer Multi-Strategy AB0.64%still open
August 6, 2025Brummer Multi-Strategy AB0.72%still open
August 4, 2025Brummer Multi-Strategy AB1.37%still open
August 1, 2025Brummer Multi-Strategy AB0.82%still open
August 27, 2024Citadel Securities (Europe) Limited0.56%still open
August 23, 2024Citadel Securities (Europe) Limited0.64%still open
August 14, 2024Citadel Securities (Europe) Limited0.74%still open
August 12, 2024Citadel Securities (Europe) Limited0.50%still open
May 16, 2024Guevoura Fund0.75%still open
May 15, 2024Guevoura Fund0.67%still open
May 15, 2024Millennium Capital Partners LLP0.62%still open
May 7, 2024Millennium Capital Partners LLP1.23%still open
April 30, 2024Millennium Capital Partners LLP1.12%still open
April 29, 2024Millennium Capital Partners LLP0.98%still open
April 26, 2024Millennium Capital Partners LLP0.75%still open
April 25, 2024Millennium Capital Partners LLP0.58%still open
March 1, 2023Voleon Capital Management LP0.68%still open
February 24, 2023Voleon Capital Management LP0.76%still open
February 21, 2023Voleon Capital Management LP0.88%still open
February 17, 2023Voleon Capital Management LP0.98%still open

Other companies sold short in Sweden

Download as CSV

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Oncopeptides AB, source Finansinspektionen, data as at August 11, 2026, https://www.quivad.com/action/oncopeptides-ab